Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 6Recruiting 3Active not recruiting 2Withdrawn 1Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3Other solid neoplasm 3

Conditions

Carcinoma, Non-Small-Cell Lung 103Lung Neoplasms 44Breast Neoplasms 41Triple Negative Breast Neoplasms 34Ovarian Neoplasms 28Small Cell Lung Carcinoma 26Squamous Cell Carcinoma of Head and Neck 23Fallopian Tube Neoplasms 18Endometrial Neoplasms 17Neoplasms 16Neoplasm Metastasis 13Head and Neck Neoplasms 13Uterine Cervical Neoplasms 12Esophageal Squamous Cell Carcinoma 12Prostatic Neoplasms 10Parkinson Disease 4, Autosomal Dominant Lewy Body 10Esophageal Neoplasms 10Colorectal Neoplasms 9Recurrence 8Carcinoma, Transitional Cell 8Oropharyngeal Neoplasms 7Carcinoma, Squamous Cell 7Neuroblastoma 6Carcinoma, Ovarian Epithelial 6Urinary Bladder Neoplasms 5Mesothelioma 5Lymphoma, Large B-Cell, Diffuse 5Lung Diseases 5Adenocarcinoma of Lung 5Thoracic Neoplasms 4

Interventions

Pemetrexed 4Cisplatin 4pembrolizumab 3Nivolumab 3Interleukin-2 3Carboplatin 3atezolizumab 2aldesleukin 2Pharmaceutical Preparations 2Ipilimumab 2olaparib 1lenvatinib 1fludarabine 1enzalutamide 1Thoracoscopy 1Thoracic Surgery, Video-Assisted 1Surgery, Computer-Assisted 1Proton Therapy 1Platinum 1Paclitaxel 1Injections 1Influenza Vaccines 1Indocyanine Green 1In Situ Hybridization, Fluorescence 1Cyclophosphamide 1Combined Modality Therapy 1Cerebral Decortication 1Brentuximab Vedotin 1Blood Component Removal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Mesothelioma, Malignant × Carboplatin × Clear all
NCT06097728 2026-04-28

eVOLVE-Meso

AstraZeneca

Phase 3 Recruiting
825 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06057935 2025-07-22

A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
64 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT06318286 2025-05-25

PENINSULA

Hyogo Medical University

Phase 2 Recruiting
25 enrolled
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡